摘要:
Disclosed herein are compounds having the structure of Formula I and pharmaceutically suitable salts, esters, and prodrugs thereof that are useful as antibacterially effective tricyclic gyrase inhibitors.Related pharmaceutical compositions, uses and methods of making the compounds are also contemplated.
摘要:
Disclosed herein are compounds having the structure of Formula I and pharmaceutically suitable salts, esters, and prodrugs thereof that are useful as antibacterially effective tricyclic gyrase inhibitors.Related pharmaceutical compositions, uses and methods of making the compounds are also contemplated.
摘要:
An input/output (I/O) controller in an I/O system processes I/O requests from a host computer to a plurality of I/O devices. The I/O controller generates an interrupt to the host computer and reports a plurality of completed I/O requests from the I/O devices when at least one condition of the I/O system is met. A first condition of the I/O system comprises a predetermined ratio between the total number of unreported I/O completions by the I/O devices and the total number of remaining I/O requests from the host computer. A second condition comprises the expiration of a timer, which starts when the number of remaining I/O requests left to process for any individual I/O device reaches a predetermined minimum limit.
摘要:
Small molecule compounds and compositions containing said compounds useful for inhibiting signaling by certain Toll-like receptors (TLRs), particularly TLR9, are provided. The compounds and compositions can be used to inhibit immune responses, including unwanted immune responses in particular. Compounds, compositions, and methods are provided to treat a variety of conditions involving unwanted immune responses, including for example autoimmune disease, inflammation, transplant rejection, and sepsis.